Honeywell 4Q Profit Rises on Higher Sales
By Dean Seal
Honeywell recorded higher earnings and sales in the fourth quarter and laid out guidance for further growth in the new year.
The industrial conglomerate posted a profit of $1.26 billion, or $1.91 a share, compared with $1.02 billion, or $1.51 a share, in the same quarter a year ago.
Stripping out one-time items, adjusted earnings were $2.60 a share. Analysts polled by FactSet had been expecting $2.59 a share.
Revenue rose to $9.44 billion from $9.19 billion, missing analyst projections for $9.7 billion, according to FactSet.
Sales were up 2% on an organic basis, led by double-digit percentage growth in commercial aviation. The company's building technologies business saw a 1% drop in organic sales due to lower volumes of fire and security offerings, offsetting growth from strength in services and projects.
The top line of its performance materials and technologies segment were up 4%, but revenue in Honeywell's safety and productivity business was down 24% on an organic basis.
Honeywell said its backlog remains at a record level, ending the year up 8% at $31.8 billion.
The Charlotte-based company is expecting adjusted earnings of $9.80 to $10.10 a share in 2024, in line with current analyst forecasts for $9.96 a share.
Revenue in the next year is expected to hit $38.1 billion to $38.9 billion, below current analyst expectations for an even $39 billion, according to FactSet.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
February 01, 2024 06:32 ET (11:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth